Sebastian Hörner joined BiconY Therapeutics as a Senior Scientist in 2023. He studied technical biology at the University of Stuttgart from 2011 to 2017, where he started his work in the field of recombinant antibodies in the lab of Roland Kontermann. From 2017 to 2021, he worked as a PhD candidate in the group of Gundram Jung in the Department of Immunology at the University of Tübingen. Between 2021 and 2023, he was a postdoctoral research fellow in the group of Helmut Salih in the Clinical Cooperation Unit Translational Immunology at the University Hospital Tübingen. His current research interest is the development of bispecific costimulatory antibodies.